CCDC 1415366: Experimental Crystal Structure Determination
Rainer E. Martin(Roche (Switzerland)), A. Mayweg(Roche (Switzerland)), André Alker(Roche (Switzerland)), Xuefei Tan(Roche (China)), Philippe Verry(Roche (Switzerland)), William Riboulet(Roche (Switzerland)), Bernd Kuhn, Giorgio Ottaviani(Roche (China)), Hans Peter Märki(Roche (Switzerland)), Dominique Burger(Roche (Switzerland)), Hans-Jakob Krebs(Roche (Switzerland)), A. Kuglstatter(Roche (Switzerland)), Stephan Müller(Roche (Switzerland)), Kurt E. Amrein(Roche (Switzerland)), Johannes D. Aebi(Roche (Switzerland)), Benoit Hornsperger(Roche (Switzerland))
Cited by 0
Related Papers
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction
|ACS Medicinal Chemistry Letters|2014|174
Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors
|Journal of Medicinal Chemistry|2017|141
β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease
|Journal of Medicinal Chemistry|2013|138
A Real-World Perspective on Molecular Design
|Journal of Medicinal Chemistry|2016|120